This website uses cookies to ensure you get the best experience on the website.If you continue to browse, then you agree to our Cookie Policy and Privacy Policy.
The Society for Immunotherapy of Cancer (SITC) aims to improve cancer patient outcomes by advancing the science, development, and application of cancer immunology and immunotherapy. SITC works towards making cancer immunotherapy a standard of care and bringing the word 'cure' to reality for cancer patients everywhere.
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations from the Society for Immunotherapy of Cancer & the International Bladder Cancer Group. Join the webinar on March 18, 2024, from 4-5 p.m. CST to discuss the publication in-depth with experts.